Table 4 Comparison of the clinical data in the non-malignant and malignant lesion group
From: Selecting treatment method for ovarian masses in children – 24 years of experience
Malignant | Non-malignant | p value | |
|---|---|---|---|
Number of patients | 22 | 192 | |
Age(years) | 10.0 (7.0÷14.0) | 14.0 (8.0÷16.0) | 0.134 |
0-1 | 0 | 30/ 15.63% | |
2-4 | 3/ 13.64% | 5/ 2.60% | |
5-8 | 7/ 31.82% | 19/ 9.90% | |
9-14 | 6/ 27.27% | 63/ 32.81% | |
15-18 | 6/ 27.27% | 75/ 39.06% | |
<14 years | 16 | 94 | 0.027 |
>14 years | 6 | 98 | |
Symptoms | |||
abdominal pain | 11/ 50% | 116/ 60.42% | |
palpable mass | 18/ 81.82% | 58/ 30.21% | |
distension | 13/ 59.9% | 27/ 14.06% | |
Us Result | 19/ 86.36% | 180/ 93.75% | |
solid | 9/ 47.37% | 10/ 5.55% | <0.05 (in association with positive tumor markers) |
complex | 10/ 52.63% | 46/ 25.55% | |
cystic | 0/ 0.00% | 124/ 68.89% | |
Size Of The Lesion | <0.001 | ||
large lesion | 17/ 77.27% | 63/ 32.81% | |
lesion that was not described as large | 5/ 22.73% | 129/ 67.19% | |
Bilateral Lesion | 3/ 13.64% | 11/ 5.73% | |
Tumor Markers | <0.00000 | ||
positive | 14/20 (70.00%) | 14/102(13.72%) | |
negative | 6/20 (30%) | 88/102(86.28%) | |